Pushing Forward the DNA Walkers in Connection with Tumor-Derived Extracellular Vesicles

Int J Nanomedicine. 2024 Jun 19:19:6231-6252. doi: 10.2147/IJN.S464895. eCollection 2024.

Abstract

Extracellular vesicles (EVs) are microparticles released from cells in both physiological and pathological conditions and could be used to monitor the progression of various pathological states, including neoplastic diseases. In various EVs, tumor-derived extracellular vesicles (TEVs) are secreted by different tumor cells and are abundant in many molecular components, such as proteins, nucleic acids, lipids, and carbohydrates. TEVs play a crucial role in forming and advancing various cancer processes. Therefore, TEVs are regarded as promising biomarkers for the early detection of cancer in liquid biopsy. However, the currently developed TEV detection methods still face several key scientific problems that need to be solved, such as low sensitivity, poor specificity, and poor accuracy. To overcome these limitations, DNA walkers have emerged as one of the most popular nanodevices that exhibit better signal amplification capability and enable highly sensitive and specific detection of the analytes. Due to their unique properties of high directionality, flexibility, and efficiency, DNA walkers hold great potential for detecting TEVs. This paper provides an introduction to EVs and DNA walker, additionally, it summarizes recent advances in DNA walker-based detection of TEVs (2018-2024). The review highlights the close relationship between TEVs and DNA walkers, aims to offer valuable insights into TEV detection and to inspire the development of reliable, efficient, simple, and innovative methods for detecting TEVs based on DNA walker in the future.

Keywords: DNA walker; EVs; TEVs; detection.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • DNA* / chemistry
  • Early Detection of Cancer / methods
  • Extracellular Vesicles* / chemistry
  • Humans
  • Liquid Biopsy / methods
  • Neoplasms* / metabolism

Substances

  • DNA
  • Biomarkers, Tumor

Grants and funding

This work was supported by the Hunan Provincial Natural Science Foundation (Grant No. 2024JJ8237) and Key R&D Plan of Hunan Provincial Department of Science and Technology (Grant No. 2023SK2046) and Opening Funding of Traditional Chinese Medicine and Ethnomedicine Innovation & Development International Laboratory (Grant No. 2022GJSYS07) and National Natural Science Foundation of China (Grant No. 82304890) and the Changsha Natural Science Foundation (Grant No. Kq2208193).